Expert CRO for Musculoskeletal Trials | Full-Service, Global Reach
NBCD is a leading research services provider, specializing in osteoarthritis clinical research. With a focus on intelligent feasibility and study design, NBCD helps clients advance drug candidates through all phases of clinical trials, with particular expertise in mitigating placebo response. NBCD is a full-service CRO specializing in osteoarthritis research. The company headquarters are located at Telefonvej 8D, 2., Søborg, Capital Region 2860, DK.
NBCD operates with a global reach, conducting clinical trials in Europe, the USA, Asia, and Latin America. The company is dedicated to providing comprehensive support throughout the clinical trial process, ensuring the highest standards of quality and efficiency. NBCD's knowledge and experience in osteoarthritis clinical research make them a valuable partner for companies seeking to develop innovative treatments.
NBCD is committed to driving advancements in osteoarthritis research and improving patient outcomes. NBCD continually strives to enhance its capabilities and expand its global presence. We invite the manager of NBCD to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence and commercial development.
NBCD er en førende leverandør af forskningsservices, der specialiserer sig i klinisk forskning inden for slidgigt. Med fokus på intelligent gennemførlighed og studiedesign hjælper NBCD klienter med at fremme lægemiddelkandidater gennem alle faser af kliniske forsøg, med særlig ekspertise i at mindske placebo-responsen. NBCD er en full-service CRO, der specialiserer sig i slidgigtforskning. Virksomhedens hovedkvarter ligger på Telefonvej 8D, 2., Søborg, Capital Region 2860, DK.
NBCD opererer med en global rækkevidde og udfører kliniske forsøg i Europa, USA, Asien og Latinamerika. Virksomheden er dedikeret til at yde omfattende support gennem hele den kliniske forsøgsproces og sikre de højeste standarder for kvalitet og effektivitet. NBCDs viden og erfaring inden for klinisk forskning i slidgigt gør dem til en værdifuld partner for virksomheder, der søger at udvikle innovative behandlinger.
NBCD er engageret i at fremme fremskridt inden for slidgigtforskning og forbedre patientresultater. NBCD stræber kontinuerligt efter at forbedre sine evner og udvide sin globale tilstedeværelse. Vi inviterer lederen af NBCD til at oprette en tilpasset og eksklusiv virksomhedspræsentation og produktliste på vores platform for yderligere at forbedre deres markedstilstedeværelse og kommercielle udvikling.
Compare NBCD with 3 companies in Research-Services
| Comparison Field |
NBCDMain Company |
ScientaView Profile |
ERGOMEDView Profile |
McCaig Institute for...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 1997 | 1992 |
|
Company Size
|
— | 11-50 | 1,001-5,000 | 201-500 |
|
City
|
Søborg, Capital Region | London, England | Guildford, Surrey | Calgary, Alberta |
|
Country
|
Denmark | United Kingdom | United Kingdom | Canada |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Osteoarthritis Research
Clinical Trials
Drug Development
Clinical Research
CRO Services
Placebo Response Mitigation
Pharmaceutical Research
Osteoarthritis
Clincial Trials
Clinical Development
|
8 Total
8 Unique
Unique Skills:
Clinical Operations
Life Sciences
Medical Affairs
Pharmaceuticals
Quality Assurance
Recruitment
+2
|
17 Total
17 Unique
Unique Skills:
Clinical Data Management
Clinical Project Management
Contract Research Organization
Drug Development Expertise
Global Clinical Trials
Late-Stage Clinical Programs
+11
|
18 Total
18 Unique
Unique Skills:
Basic Science
Biomarkers
Bone density
Bone Fracture
Cartilage
Clinical Imaging
+12
|
Other organizations in the same industry
This company is also known as